speb/financial-data huggingface dataset:
U balance_sheet (annual, 2023-12-31) — Total Debt: 2711750000.00
U balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 3414378000.00
U income_statement (annual, 2023-12-31) — Total Expenses: 3020111000.00
U balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 3829063000.00
U balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 4918550000.00
U balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 2934960000.00
U income_statement (annual, 2023-12-31) — Total Operating Income As Reported: -832794000.00
U balance_sheet (annual, 2023-12-31) — Total Tax Payable: 90809000.00
U balance_sheet (annual, 2023-12-31) — Working Capital: 1430788000.00
U balance_sheet (quarterly, 2024-09-30) — Cash Equivalents: 297426000.00
U balance_sheet (quarterly, 2024-09-30) — Cash Financial: 1107850000.00
U cash_flow (quarterly, 2024-09-30) — Income Tax Paid Supplemental Data: 3034000.00
U cash_flow (quarterly, 2024-09-30) — Interest Paid Supplemental Data: 0.00
U cash_flow (quarterly, 2024-09-30) — Net Intangibles Purchase And Sale: -12500000.00
U cash_flow (quarterly, 2024-09-30) — Net Investment Purchase And Sale: 0.00
U cash_flow (quarterly, 2024-09-30) — Purchase Of Intangibles: -12500000.00
U cash_flow (quarterly, 2024-09-30) — Purchase Of Investment: 0.00
U cash_flow (quarterly, 2024-09-30) — Sale Of Investment: 0.00
U income_statement (annual, 2024-12-31) — +Operating Expense: 2087551000.00
U income_statement (annual, 2024-12-31) — +Total Revenue: 1813255000.00
U balance_sheet (annual, 2024-12-31) — Accounts Payable: 13948000.00
U balance_sheet (annual, 2024-12-31) — Accounts Receivable: 573884000.00
U balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -169950000.00
U balance_sheet (quarterly, 2024-12-31) — Accumulated Depreciation: -169950000.00
U balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 6936038000.00
U balance_sheet (annual, 2024-12-31) — Allowance For Doubtful Accounts Receivable: -17300000.00
U cash_flow (annual, 2024-12-31) — Amortization Cash Flow: 353371000.00
U cash_flow (annual, 2024-12-31) — Amortization Of Intangibles: 353371000.00
U cash_flow (annual, 2024-12-31) — Asset Impairment Charge: 22791000.00
U income_statement (annual, 2024-12-31) — Basic Average Shares: 395951000.00
U income_statement (annual, 2024-12-31) — Basic EPS: -1.68
U cash_flow (annual, 2024-12-31) — Beginning Cash Position: 1604267000.00
U cash_flow (annual, 2024-12-31) — Capital Expenditure: -42409000.00
U balance_sheet (annual, 2024-12-31) — Capital Stock: 2000.00
U balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 1517672000.00
U balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 1517672000.00
U cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: -338307000.00
U cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: -42409000.00
U cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: 315553000.00
U cash_flow (annual, 2024-12-31) — Change In Account Payable: 742000.00
U cash_flow (annual, 2024-12-31) — Change In Accrued Expense: -6671000.00
U cash_flow (annual, 2024-12-31) — Change In Other Current Assets: -2746000.00
U cash_flow (annual, 2024-12-31) — Change In Other Current Liabilities: -47963000.00
U cash_flow (annual, 2024-12-31) — Change In Other Working Capital: 11194000.00
U cash_flow (annual, 2024-12-31) — Change In Payable: 9912000.00
U cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: 3241000.00
U cash_flow (annual, 2024-12-31) — Change In Prepaid Assets: -11203000.00
U cash_flow (annual, 2024-12-31) — Change In Receivables: 37359000.00
U cash_flow (annual, 2024-12-31) — Change In Working Capital: -10118000.00
U cash_flow (annual, 2024-12-31) — Changes In Account Receivables: 37359000.00
U cash_flow (annual, 2024-12-31) — Changes In Cash: -65163000.00
U balance_sheet (annual, 2024-12-31) — Common Stock: 2000.00
U balance_sheet (annual, 2024-12-31) — Common Stock Equity: 3190671000.00
U cash_flow (annual, 2024-12-31) — Common Stock Payments: 0.00
U cash_flow (quarterly, 2024-12-31) — Common Stock Payments: 0.00
U balance_sheet (annual, 2024-12-31) — Construction In Progress: 14073000.00
U balance_sheet (quarterly, 2024-12-31) — Construction In Progress: 14073000.00
U income_statement (annual, 2024-12-31) — Cost Of Revenue: 480853000.00
U balance_sheet (annual, 2024-12-31) — Current Accrued Expenses: 124414000.00
U balance_sheet (annual, 2024-12-31) — Current Assets: 2225351000.00
U balance_sheet (annual, 2024-12-31) — Current Deferred Liabilities: 186304000.00
U balance_sheet (annual, 2024-12-31) — Current Deferred Revenue: 186304000.00
U balance_sheet (annual, 2024-12-31) — Current Liabilities: 889487000.00
U cash_flow (annual, 2024-12-31) — Depreciation: 55609000.00
U cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 408980000.00
U cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 408980000.00
U income_statement (annual, 2024-12-31) — Diluted Average Shares: 395951000.00
U income_statement (annual, 2024-12-31) — Diluted EPS: -1.68
U income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: -664114000.00
U income_statement (annual, 2024-12-31) — EBIT: -643591000.00
U income_statement (annual, 2024-12-31) — EBITDA: -234611000.00
U cash_flow (annual, 2024-12-31) — Effect Of Exchange Rate Changes: -11223000.00
U cash_flow (annual, 2024-12-31) — End Cash Position: 1527881000.00
U cash_flow (annual, 2024-12-31) — Financing Cash Flow: -338307000.00
U cash_flow (annual, 2024-12-31) — Free Cash Flow: 273144000.00
U balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: -9425000.00
U income_statement (annual, 2024-12-31) — General And Administrative Expense: 410072000.00
U balance_sheet (annual, 2024-12-31) — Goodwill: 3166304000.00
U balance_sheet (annual, 2024-12-31) — Goodwill And Other Intangible Assets: 4232539000.00
U balance_sheet (annual, 2024-12-31) — Gross Accounts Receivable: 591184000.00
U balance_sheet (annual, 2024-12-31) — Gross PPE: 268769000.00
U balance_sheet (quarterly, 2024-12-31) — Gross PPE: 268769000.00
U income_statement (annual, 2024-12-31) — Gross Profit: 1332402000.00
U cash_flow (annual, 2024-12-31) — Income Tax Paid Supplemental Data: 26363000.00
U cash_flow (quarterly, 2024-12-31) — Income Tax Paid Supplemental Data: 7022000.00
U balance_sheet (annual, 2024-12-31) — Income Tax Payable: 96497000.00
U balance_sheet (quarterly, 2024-12-31) — Income Tax Payable: 96497000.00
U income_statement (annual, 2024-12-31) — Interest Expense: 23542000.00
U income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 23542000.00
U income_statement (annual, 2024-12-31) — Interest Income: 111558000.00
U income_statement (annual, 2024-12-31) — Interest Income Non Operating: 111558000.00
U cash_flow (annual, 2024-12-31) — Interest Paid Supplemental Data: 20000000.00
U cash_flow (quarterly, 2024-12-31) — Interest Paid Supplemental Data: 10000000.00
U balance_sheet (annual, 2024-12-31) — Invested Capital: 5429593000.00
U cash_flow (annual, 2024-12-31) — Investing Cash Flow: -42409000.00
U cash_flow (annual, 2024-12-31) — Issuance Of Debt: 0.00
U balance_sheet (annual, 2024-12-31) — Leases: 76862000.00
U balance_sheet (quarterly, 2024-12-31) — Leases: 76862000.00
U balance_sheet (annual, 2024-12-31) — Long Term Debt: 2238922000.00
U balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 2238922000.00
U cash_flow (annual, 2024-12-31) — Long Term Debt Issuance: 0.00
U cash_flow (annual, 2024-12-31) — Long Term Debt Payments: -414999000.00
U balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 177834000.00
U balance_sheet (quarterly, 2024-12-31) — Machinery Furniture Equipment: 177834000.00
U balance_sheet (annual, 2024-12-31) — Minority Interest: 236477000.00
U income_statement (annual, 2024-12-31) — Minority Interests: 173000.00
U cash_flow (annual, 2024-12-31) — Net Business Purchase And Sale: 0.00
U cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: 0.00
U cash_flow (quarterly, 2024-12-31) — Net Common Stock Issuance: 0.00
U balance_sheet (annual, 2024-12-31) — Net Debt: 721250000.00
U income_statement (annual, 2024-12-31) — Net Income: -664114000.00
U income_statement (annual, 2024-12-31) — Net Income Common Stockholders: -664114000.00
U income_statement (annual, 2024-12-31) — Net Income Continuous Operations: -664287000.00
U income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: -664114000.00
U income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: -664114000.00
U cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: -664287000.00
U income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: -664287000.00
U cash_flow (annual, 2024-12-31) — Net Intangibles Purchase And Sale: -12860000.00
U cash_flow (quarterly, 2024-12-31) — Net Intangibles Purchase And Sale: 0.00
U income_statement (annual, 2024-12-31) — Net Interest Income: 88016000.00
U cash_flow (annual, 2024-12-31) — Net Investment Purchase And Sale: 0.00
U cash_flow (quarterly, 2024-12-31) — Net Investment Purchase And Sale: 0.00
U cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: -414999000.00
U cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: -414999000.00
U income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: 88016000.00
U balance_sheet (annual, 2024-12-31) — Net PPE: 98819000.00
U cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -29549000.00
U balance_sheet (annual, 2024-12-31) — Net Tangible Assets: -1041868000.00
U balance_sheet (annual, 2024-12-31) — Non Current Deferred Liabilities: 16846000.00
U balance_sheet (annual, 2024-12-31) — Non Current Deferred Revenue: 16846000.00
U income_statement (annual, 2024-12-31) — Normalized EBITDA: -234611000.00
U income_statement (annual, 2024-12-31) — Normalized Income: -664114000.00
U cash_flow (annual, 2024-12-31) — Operating Cash Flow: 315553000.00
U income_statement (annual, 2024-12-31) — Operating Income: -755149000.00
U income_statement (annual, 2024-12-31) — Operating Revenue: 1813255000.00
U balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 409392524.00
U balance_sheet (annual, 2024-12-31) — Other Current Assets: 133795000.00
U balance_sheet (annual, 2024-12-31) — Other Equity Adjustments: -9425000.00
U income_statement (annual, 2024-12-31) — Other Gand A: 410072000.00
U balance_sheet (annual, 2024-12-31) — Other Intangible Assets: 1066235000.00
U cash_flow (annual, 2024-12-31) — Other Non Cash Items: -38062000.00
U balance_sheet (annual, 2024-12-31) — Other Non Current Assets: 180698000.00
U balance_sheet (annual, 2024-12-31) — Other Non Current Liabilities: 165004000.00
U balance_sheet (annual, 2024-12-31) — Other Payable: 394284000.00
U balance_sheet (annual, 2024-12-31) — Payables: 504729000.00
U balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 629143000.00
U balance_sheet (annual, 2024-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 74040000.00
U balance_sheet (quarterly, 2024-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 74040000.00
U income_statement (annual, 2024-12-31) — Pretax Income: -667133000.00
U cash_flow (annual, 2024-12-31) — Proceeds From Stock Option Exercised: 76692000.00
U balance_sheet (annual, 2024-12-31) — Properties: 0.00
U balance_sheet (quarterly, 2024-12-31) — Properties: 0.00
U cash_flow (annual, 2024-12-31) — Purchase Of Intangibles: -12860000.00
U cash_flow (quarterly, 2024-12-31) — Purchase Of Intangibles: 0.00
U cash_flow (annual, 2024-12-31) — Purchase Of Investment: 0.00
U cash_flow (quarterly, 2024-12-31) — Purchase Of Investment: 0.00
U cash_flow (annual, 2024-12-31) — Purchase Of PPE: -29549000.00
U balance_sheet (annual, 2024-12-31) — Receivables: 573884000.00
U income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 480853000.00
U income_statement (annual, 2024-12-31) — Reconciled Depreciation: 408980000.00
U cash_flow (annual, 2024-12-31) — Repayment Of Debt: -414999000.00
U cash_flow (annual, 2024-12-31) — Repurchase Of Capital Stock: 0.00
U cash_flow (quarterly, 2024-12-31) — Repurchase Of Capital Stock: 0.00
U income_statement (annual, 2024-12-31) — Research And Development: 924830000.00
U balance_sheet (annual, 2024-12-31) — Retained Earnings: -3735944000.00
U cash_flow (annual, 2024-12-31) — Sale Of Business: 0.00
U cash_flow (annual, 2024-12-31) — Sale Of Investment: 0.00
U cash_flow (quarterly, 2024-12-31) — Sale Of Investment: 0.00
U income_statement (annual, 2024-12-31) — Selling And Marketing Expense: 752649000.00
U income_statement (annual, 2024-12-31) — Selling General And Administration: 1162721000.00
U balance_sheet (annual, 2024-12-31) — Share Issued: 409392524.00
U cash_flow (annual, 2024-12-31) — Stock Based Compensation: 596249000.00
U balance_sheet (annual, 2024-12-31) — Stockholders Equity: 3190671000.00
U balance_sheet (annual, 2024-12-31) — Tangible Book Value: -1041868000.00
U income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
U income_statement (annual, 2024-12-31) — Tax Provision: -2846000.00
U income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.00
U balance_sheet (annual, 2024-12-31) — Total Assets: 6737407000.00
U balance_sheet (annual, 2024-12-31) — Total Capitalization: 5429593000.00
U balance_sheet (annual, 2024-12-31) — Total Debt: 2238922000.00
U balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 3427148000.00
U income_statement (annual, 2024-12-31) — Total Expenses: 2568404000.00
U balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 3310259000.00
U balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 4512056000.00
U balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 2420772000.00
U income_statement (annual, 2024-12-31) — Total Operating Income As Reported: -755149000.00
U balance_sheet (annual, 2024-12-31) — Total Tax Payable: 96497000.00
U balance_sheet (quarterly, 2024-12-31) — Total Tax Payable: 96497000.00
U balance_sheet (annual, 2024-12-31) — Working Capital: 1335864000.00
U income_statement (quarterly, 2025-03-31) — +Operating Expense: 448978000.00
U income_statement (quarterly, 2025-03-31) — +Total Revenue: 435000000.00
U balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 16538000.00
U balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 552958000.00
U balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 7008134000.00
U balance_sheet (quarterly, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -15600000.00
U cash_flow (quarterly, 2025-03-31) — Amortization Cash Flow: 10567000.00
U cash_flow (quarterly, 2025-03-31) — Amortization Of Intangibles: 10567000.00
U cash_flow (quarterly, 2025-03-31) — Asset Impairment Charge: 3470000.00
U income_statement (quarterly, 2025-03-31) — Basic Average Shares: 411852000.00
U income_statement (quarterly, 2025-03-31) — Basic EPS: -0.19
U cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 1527881000.00
U cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -5718000.00
U balance_sheet (quarterly, 2025-03-31) — Capital Stock: 2000.00
U balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 1541170000.00
U balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 1541170000.00
U cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: 12248000.00
U cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: -5718000.00
U cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: 13026000.00
U cash_flow (quarterly, 2025-03-31) — Change In Account Payable: 2198000.00
U cash_flow (quarterly, 2025-03-31) — Change In Accrued Expense: -21029000.00
U cash_flow (quarterly, 2025-03-31) — Change In Other Current Assets: 10023000.00
U cash_flow (quarterly, 2025-03-31) — Change In Other Current Liabilities: -10919000.00
U cash_flow (quarterly, 2025-03-31) — Change In Other Working Capital: -120000.00
U cash_flow (quarterly, 2025-03-31) — Change In Payable: -52957000.00
U cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: -73986000.00
U cash_flow (quarterly, 2025-03-31) — Change In Prepaid Assets: -10602000.00
U cash_flow (quarterly, 2025-03-31) — Change In Receivables: 21022000.00
U cash_flow (quarterly, 2025-03-31) — Change In Working Capital: -64582000.00
U cash_flow (quarterly, 2025-03-31) — Changes In Account Receivables: 21022000.00
U cash_flow (quarterly, 2025-03-31) — Changes In Cash: 19556000.00
U balance_sheet (quarterly, 2025-03-31) — Common Stock: 2000.00
U balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 3186049000.00
U income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 113957000.00
U balance_sheet (quarterly, 2025-03-31) — Current Accrued Expenses: 273444000.00
U balance_sheet (quarterly, 2025-03-31) — Current Assets: 2238642000.00
U balance_sheet (quarterly, 2025-03-31) — Current Deferred Liabilities: 188490000.00
U balance_sheet (quarterly, 2025-03-31) — Current Deferred Revenue: 188490000.00
U balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 817601000.00
U cash_flow (quarterly, 2025-03-31) — Depreciation: 85650000.00
U cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 96217000.00
U cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 96217000.00
U income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 411852000.00
U income_statement (quarterly, 2025-03-31) — Diluted EPS: -0.19
U income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: -77642000.00
U income_statement (quarterly, 2025-03-31) — EBIT: -69824000.00
U income_statement (quarterly, 2025-03-31) — EBITDA: 26393000.00
U cash_flow (quarterly, 2025-03-31) — Effect Of Exchange Rate Changes: 4197000.00
U cash_flow (quarterly, 2025-03-31) — End Cash Position: 1551634000.00
U cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: 12248000.00
U cash_flow (quarterly, 2025-03-31) — Free Cash Flow: 7308000.00
U balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: -8501000.00
U income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 66340000.00
U balance_sheet (quarterly, 2025-03-31) — Goodwill: 3166304000.00
U balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 4146888000.00
U balance_sheet (quarterly, 2025-03-31) — Gross Accounts Receivable: 568558000.00
U balance_sheet (quarterly, 2025-03-31) — Gross PPE: 89972000.00
U income_statement (quarterly, 2025-03-31) — Gross Profit: 321043000.00
U income_statement (quarterly, 2025-03-31) — Interest Expense: 5891000.00
U income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 5891000.00
U income_statement (quarterly, 2025-03-31) — Interest Income: 58111000.00
U income_statement (quarterly, 2025-03-31) — Interest Income Non Operating: 58111000.00
U balance_sheet (quarterly, 2025-03-31) — Invested Capital: 5418192000.00
U cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -5718000.00
U cash_flow (quarterly, 2025-03-31) — Issuance Of Debt: 690000000.00
U balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 2232143000.00
U balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 2232143000.00
U cash_flow (quarterly, 2025-03-31) — Long Term Debt Issuance: 690000000.00
U cash_flow (quarterly, 2025-03-31) — Long Term Debt Payments: -641691000.00
U balance_sheet (quarterly, 2025-03-31) — Minority Interest: 240589000.00
U income_statement (quarterly, 2025-03-31) — Minority Interests: 265000.00
U balance_sheet (quarterly, 2025-03-31) — Net Debt: 690973000.00
U income_statement (quarterly, 2025-03-31) — Net Income: -77642000.00
U income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: -77642000.00
U income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: -77907000.00
U income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: -77642000.00
U income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: -77642000.00
U cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: -77907000.00
U income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: -77907000.00
U income_statement (quarterly, 2025-03-31) — Net Interest Income: 52220000.00
U cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: 48309000.00
U cash_flow (quarterly, 2025-03-31) — Net Long Term Debt Issuance: 48309000.00
U income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: 52220000.00
U cash_flow (quarterly, 2025-03-31) — Net Other Financing Charges: -57672000.00
U balance_sheet (quarterly, 2025-03-31) — Net PPE: 89972000.00
U cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -5718000.00
U balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: -960839000.00
U balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Liabilities: 14710000.00
U balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Revenue: 14710000.00
U income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 26393000.00
U income_statement (quarterly, 2025-03-31) — Normalized Income: -77642000.00
U cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: 13026000.00
U cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: -42744000.00
U income_statement (quarterly, 2025-03-31) — Operating Income: -127935000.00
U income_statement (quarterly, 2025-03-31) — Operating Revenue: 435000000.00
U balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 415406492.00
U balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 144514000.00
U balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: -8501000.00
U income_statement (quarterly, 2025-03-31) — Other Gand A: 66340000.00
U balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 980584000.00
U cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: -218000.00
U balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 170453000.00
U balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 154863000.00
U balance_sheet (quarterly, 2025-03-31) — Other Payable: 339129000.00
U balance_sheet (quarterly, 2025-03-31) — Other Properties: 89972000.00
U balance_sheet (quarterly, 2025-03-31) — Payables: 355667000.00
U balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 629111000.00
U income_statement (quarterly, 2025-03-31) — Pretax Income: -75715000.00
U cash_flow (quarterly, 2025-03-31) — Proceeds From Stock Option Exercised: 21611000.00
U cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -5718000.00
U balance_sheet (quarterly, 2025-03-31) — Receivables: 552958000.00
U income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 113957000.00
U income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 96217000.00
U cash_flow (quarterly, 2025-03-31) — Repayment Of Debt: -641691000.00
U income_statement (quarterly, 2025-03-31) — Research And Development: 220625000.00
U balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -3813586000.00
U income_statement (quarterly, 2025-03-31) — Selling And Marketing Expense: 162013000.00
U income_statement (quarterly, 2025-03-31) — Selling General And Administration: 228353000.00
U balance_sheet (quarterly, 2025-03-31) — Share Issued: 415406492.00
U cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 98790000.00
U balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 3186049000.00
U balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: -960839000.00
U income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
U income_statement (quarterly, 2025-03-31) — Tax Provision: 2192000.00
U income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.21
U balance_sheet (quarterly, 2025-03-31) — Total Assets: 6645955000.00
U balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 5418192000.00
U balance_sheet (quarterly, 2025-03-31) — Total Debt: 2232143000.00
U balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 3426638000.00
U income_statement (quarterly, 2025-03-31) — Total Expenses: 562935000.00
U balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 3219317000.00
U balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 4407313000.00
U balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 2401716000.00
U income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: -127935000.00
U balance_sheet (quarterly, 2025-03-31) — Working Capital: 1421041000.00
U income_statement (quarterly, 2025-06-30) — +Operating Expense: 445485000.00
U income_statement (quarterly, 2025-06-30) — +Total Revenue: 440944000.00
U balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 12248000.00
U balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 596560000.00
U balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 7116124000.00
U balance_sheet (quarterly, 2025-06-30) — Allowance For Doubtful Accounts Receivable: -13200000.00
U cash_flow (quarterly, 2025-06-30) — Asset Impairment Charge: 579000.00
U income_statement (quarterly, 2025-06-30) — Basic Average Shares: 417566000.00
U income_statement (quarterly, 2025-06-30) — Basic EPS: -0.26
U cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 1551634000.00
U cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -6446000.00
U balance_sheet (quarterly, 2025-06-30) — Capital Stock: 2000.00
U balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 1691045000.00
U balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 1691045000.00
U balance_sheet (quarterly, 2025-06-30) — Cash Equivalents: 861472000.00
U balance_sheet (quarterly, 2025-06-30) — Cash Financial: 829573000.00
U cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: 9783000.00
U cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -8446000.00
U cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: 133096000.00
U cash_flow (quarterly, 2025-06-30) — Change In Account Payable: -4297000.00
U cash_flow (quarterly, 2025-06-30) — Change In Accrued Expense: 7417000.00
U cash_flow (quarterly, 2025-06-30) — Change In Other Current Assets: 1866000.00
U cash_flow (quarterly, 2025-06-30) — Change In Other Current Liabilities: -1942000.00
U cash_flow (quarterly, 2025-06-30) — Change In Other Working Capital: 31180000.00
U cash_flow (quarterly, 2025-06-30) — Change In Payable: 29293000.00
U cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: 36710000.00
U cash_flow (quarterly, 2025-06-30) — Change In Prepaid Assets: 24373000.00
U cash_flow (quarterly, 2025-06-30) — Change In Receivables: -43083000.00
U cash_flow (quarterly, 2025-06-30) — Change In Working Capital: 49104000.00
U cash_flow (quarterly, 2025-06-30) — Changes In Account Receivables: -43083000.00
U cash_flow (quarterly, 2025-06-30) — Changes In Cash: 134433000.00
U balance_sheet (quarterly, 2025-06-30) — Common Stock: 2000.00
U balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 3187393000.00
U income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 114211000.00
U balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 278850000.00
U balance_sheet (quarterly, 2025-06-30) — Current Assets: 2407776000.00
U balance_sheet (quarterly, 2025-06-30) — Current Deferred Liabilities: 219448000.00
U balance_sheet (quarterly, 2025-06-30) — Current Deferred Revenue: 219448000.00
U balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 883265000.00
U cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 96928000.00
U cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 96928000.00
U income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 417566000.00
U income_statement (quarterly, 2025-06-30) — Diluted EPS: -0.26
U income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: -108798000.00
U income_statement (quarterly, 2025-06-30) — EBIT: -98915000.00
U income_statement (quarterly, 2025-06-30) — EBITDA: -1987000.00
U cash_flow (quarterly, 2025-06-30) — Effect Of Exchange Rate Changes: 15440000.00
U cash_flow (quarterly, 2025-06-30) — End Cash Position: 1701507000.00
U cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: 9783000.00
U cash_flow (quarterly, 2025-06-30) — Free Cash Flow: 126650000.00
U balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: -6349000.00
U income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 69165000.00
U balance_sheet (quarterly, 2025-06-30) — Goodwill: 3166304000.00
U balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 4060671000.00
U balance_sheet (quarterly, 2025-06-30) — Gross Accounts Receivable: 609760000.00
U income_statement (quarterly, 2025-06-30) — Gross Profit: 326733000.00
U income_statement (quarterly, 2025-06-30) — Interest Expense: 6030000.00
U income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 6030000.00
U income_statement (quarterly, 2025-06-30) — Interest Income: 19837000.00
U income_statement (quarterly, 2025-06-30) — Interest Income Non Operating: 19837000.00
U balance_sheet (quarterly, 2025-06-30) — Invested Capital: 5420648000.00
U cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -8446000.00
U cash_flow (quarterly, 2025-06-30) — Issuance Of Debt: 0.00
U balance_sheet (quarterly, 2025-06-30) — Long Term Debt: 2233255000.00
U balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 2233255000.00
U cash_flow (quarterly, 2025-06-30) — Long Term Debt Issuance: 0.00
U cash_flow (quarterly, 2025-06-30) — Long Term Debt Payments: 0.00
U balance_sheet (quarterly, 2025-06-30) — Minority Interest: 246682000.00
U income_statement (quarterly, 2025-06-30) — Minority Interests: -1433000.00
U balance_sheet (quarterly, 2025-06-30) — Net Debt: 542210000.00
U income_statement (quarterly, 2025-06-30) — Net Income: -108798000.00
U income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: -108798000.00
U income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: -107365000.00
U income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: -108798000.00
U income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: -108798000.00
U cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: -107365000.00
U income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: -107365000.00
U income_statement (quarterly, 2025-06-30) — Net Interest Income: 13807000.00
U cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: 0.00
U cash_flow (quarterly, 2025-06-30) — Net Long Term Debt Issuance: 0.00
U income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: 13807000.00
U cash_flow (quarterly, 2025-06-30) — Net Other Financing Charges: 0.00
U balance_sheet (quarterly, 2025-06-30) — Net PPE: 82426000.00
U cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -6446000.00
U balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: -873278000.00
U balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Liabilities: 15480000.00
U balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Revenue: 15480000.00
U income_statement (quarterly, 2025-06-30) — Normalized EBITDA: -1987000.00
U income_statement (quarterly, 2025-06-30) — Normalized Income: -108798000.00
U cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: 133096000.00
U income_statement (quarterly, 2025-06-30) — Operating Income: -118752000.00
U income_statement (quarterly, 2025-06-30) — Operating Revenue: 440944000.00
U balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 420440864.00
U balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 120171000.00
U balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: -6349000.00
U income_statement (quarterly, 2025-06-30) — Other Gand A: 69165000.00
U balance_sheet (quarterly, 2025-06-30) — Other Intangible Assets: 894367000.00
U cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: -50498000.00
U balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 165551000.00
U balance_sheet (quarterly, 2025-06-30) — Other Non Current Liabilities: 150349000.00
U balance_sheet (quarterly, 2025-06-30) — Other Payable: 372719000.00
U balance_sheet (quarterly, 2025-06-30) — Payables: 384967000.00
U balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 663817000.00
U income_statement (quarterly, 2025-06-30) — Pretax Income: -104945000.00
U cash_flow (quarterly, 2025-06-30) — Proceeds From Stock Option Exercised: 9783000.00
U cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -6446000.00
U balance_sheet (quarterly, 2025-06-30) — Receivables: 596560000.00
U income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 114211000.00
U income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 96928000.00
U cash_flow (quarterly, 2025-06-30) — Repayment Of Debt: 0.00
U income_statement (quarterly, 2025-06-30) — Research And Development: 214807000.00
U balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -3922384000.00
U income_statement (quarterly, 2025-06-30) — Selling And Marketing Expense: 161513000.00
U income_statement (quarterly, 2025-06-30) — Selling General And Administration: 230678000.00
U balance_sheet (quarterly, 2025-06-30) — Share Issued: 420440864.00
U cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 101604000.00
U balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 3187393000.00
U balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: -873278000.00
U income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
U income_statement (quarterly, 2025-06-30) — Tax Provision: 2420000.00
U income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.21
U balance_sheet (quarterly, 2025-06-30) — Total Assets: 6716424000.00
U balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 5420648000.00
U balance_sheet (quarterly, 2025-06-30) — Total Debt: 2233255000.00
U balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 3434075000.00
U income_statement (quarterly, 2025-06-30) — Total Expenses: 559696000.00
U balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 3282349000.00
U balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 4308648000.00
U balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 2399084000.00
U income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: -118752000.00
U balance_sheet (quarterly, 2025-06-30) — Working Capital: 1524511000.00
U income_statement (quarterly, 2025-09-30) — +Operating Expense: 476139000.00
U income_statement (quarterly, 2025-09-30) — +Total Revenue: 470615000.00
U balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 20006000.00
U balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 600117000.00
U balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 7257519000.00
U balance_sheet (quarterly, 2025-09-30) — Allowance For Doubtful Accounts Receivable: -11400000.00
U cash_flow (quarterly, 2025-09-30) — Asset Impairment Charge: 862000.00
U income_statement (quarterly, 2025-09-30) — Basic Average Shares: 424296000.00
U income_statement (quarterly, 2025-09-30) — Basic EPS: -0.30
U cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 1701507000.00
U cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -4107000.00
U balance_sheet (quarterly, 2025-09-30) — Capital Stock: 2000.00
U balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 1898558000.00
U balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 1898558000.00
U balance_sheet (quarterly, 2025-09-30) — Cash Equivalents: 1104898000.00
U balance_sheet (quarterly, 2025-09-30) — Cash Financial: 793660000.00
U cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: 54082000.00
U cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -4107000.00
U cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: 155398000.00
U cash_flow (quarterly, 2025-09-30) — Change In Account Payable: 7998000.00
U cash_flow (quarterly, 2025-09-30) — Change In Accrued Expense: 17901000.00
U cash_flow (quarterly, 2025-09-30) — Change In Other Current Assets: 18669000.00
U cash_flow (quarterly, 2025-09-30) — Change In Other Current Liabilities: -18795000.00
U cash_flow (quarterly, 2025-09-30) — Change In Other Working Capital: 7264000.00
U cash_flow (quarterly, 2025-09-30) — Change In Payable: 32469000.00
U cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: 50370000.00
U cash_flow (quarterly, 2025-09-30) — Change In Prepaid Assets: -3684000.00
U cash_flow (quarterly, 2025-09-30) — Change In Receivables: -3773000.00
U cash_flow (quarterly, 2025-09-30) — Change In Working Capital: 50051000.00
U cash_flow (quarterly, 2025-09-30) — Changes In Account Receivables: -3773000.00
U cash_flow (quarterly, 2025-09-30) — Changes In Cash: 205373000.00
U balance_sheet (quarterly, 2025-09-30) — Common Stock: 2000.00
U balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 3203497000.00
U income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 120332000.00
U balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 299394000.00
U balance_sheet (quarterly, 2025-09-30) — Current Assets: 2622560000.00
U balance_sheet (quarterly, 2025-09-30) — Current Deferred Liabilities: 225645000.00
U balance_sheet (quarterly, 2025-09-30) — Current Deferred Revenue: 225645000.00
U balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 942235000.00
U cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 135893000.00
U cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 135893000.00
U income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 424296000.00
U income_statement (quarterly, 2025-09-30) — Diluted EPS: -0.30
U income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: -126362000.00
U income_statement (quarterly, 2025-09-30) — EBIT: -111408000.00
U income_statement (quarterly, 2025-09-30) — EBITDA: 24485000.00
U cash_flow (quarterly, 2025-09-30) — Effect Of Exchange Rate Changes: 2208000.00
U cash_flow (quarterly, 2025-09-30) — End Cash Position: 1909088000.00
U cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: 54082000.00
U cash_flow (quarterly, 2025-09-30) — Free Cash Flow: 151291000.00
U balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: -5278000.00
U income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 65913000.00
U balance_sheet (quarterly, 2025-09-30) — Goodwill: 3166304000.00
U balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 3935326000.00
U balance_sheet (quarterly, 2025-09-30) — Gross Accounts Receivable: 611517000.00
U income_statement (quarterly, 2025-09-30) — Gross Profit: 350283000.00
U income_statement (quarterly, 2025-09-30) — Interest Expense: 6043000.00
U income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 6043000.00
U income_statement (quarterly, 2025-09-30) — Interest Income: 14448000.00
U income_statement (quarterly, 2025-09-30) — Interest Income Non Operating: 14448000.00
U cash_flow (quarterly, 2025-09-30) — Interest Paid Supplemental Data: 0.00
U balance_sheet (quarterly, 2025-09-30) — Invested Capital: 5437804000.00
U cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -4107000.00
U cash_flow (quarterly, 2025-09-30) — Issuance Of Debt: 0.00
U balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 2234307000.00
U balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 2234307000.00
U cash_flow (quarterly, 2025-09-30) — Long Term Debt Issuance: 0.00
U cash_flow (quarterly, 2025-09-30) — Long Term Debt Payments: 0.00
U balance_sheet (quarterly, 2025-09-30) — Minority Interest: 251133000.00
U income_statement (quarterly, 2025-09-30) — Minority Interests: 466000.00
U balance_sheet (quarterly, 2025-09-30) — Net Debt: 335749000.00
U income_statement (quarterly, 2025-09-30) — Net Income: -126362000.00
U income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: -126362000.00
U income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: -126828000.00
U income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: -126362000.00
U income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: -126362000.00
U cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: -126828000.00
U income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: -126828000.00
U cash_flow (quarterly, 2025-09-30) — Net Intangibles Purchase And Sale: 0.00
U income_statement (quarterly, 2025-09-30) — Net Interest Income: 8405000.00
U cash_flow (quarterly, 2025-09-30) — Net Investment Purchase And Sale: 0.00
U cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: 0.00
U cash_flow (quarterly, 2025-09-30) — Net Long Term Debt Issuance: 0.00
U income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: 8405000.00
U cash_flow (quarterly, 2025-09-30) — Net Other Financing Charges: 0.00
U balance_sheet (quarterly, 2025-09-30) — Net PPE: 76626000.00
U cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -4107000.00
U balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: -731829000.00
U balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Liabilities: 16749000.00
U balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Revenue: 16749000.00
U income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 24485000.00
U income_statement (quarterly, 2025-09-30) — Normalized Income: -126362000.00
U cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: 155398000.00
U income_statement (quarterly, 2025-09-30) — Operating Income: -125856000.00
U income_statement (quarterly, 2025-09-30) — Operating Revenue: 470615000.00
U balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 427778084.00
U balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 123885000.00
U balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: -5278000.00
U income_statement (quarterly, 2025-09-30) — Other Gand A: 65913000.00
U balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 769022000.00
U cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: 3452000.00
U balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 148785000.00
U balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 135376000.00
U balance_sheet (quarterly, 2025-09-30) — Other Payable: 397190000.00
U balance_sheet (quarterly, 2025-09-30) — Payables: 417196000.00
U balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 716590000.00
U income_statement (quarterly, 2025-09-30) — Pretax Income: -117451000.00
U cash_flow (quarterly, 2025-09-30) — Proceeds From Stock Option Exercised: 54082000.00
U cash_flow (quarterly, 2025-09-30) — Purchase Of Intangibles: 0.00
U cash_flow (quarterly, 2025-09-30) — Purchase Of Investment: 0.00
U cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -4107000.00
U balance_sheet (quarterly, 2025-09-30) — Receivables: 600117000.00
U income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 120332000.00
U income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 135893000.00
U cash_flow (quarterly, 2025-09-30) — Repayment Of Debt: 0.00
U income_statement (quarterly, 2025-09-30) — Research And Development: 244357000.00
U balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -4048746000.00
U income_statement (quarterly, 2025-09-30) — Selling And Marketing Expense: 165869000.00
U income_statement (quarterly, 2025-09-30) — Selling General And Administration: 231782000.00
U balance_sheet (quarterly, 2025-09-30) — Share Issued: 427778084.00
U cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 91968000.00
U balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 3203497000.00
U balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: -731829000.00
U income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
U income_statement (quarterly, 2025-09-30) — Tax Provision: 9377000.00
U income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.21
U balance_sheet (quarterly, 2025-09-30) — Total Assets: 6783297000.00
U balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 5437804000.00
U balance_sheet (quarterly, 2025-09-30) — Total Debt: 2234307000.00
U balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 3454630000.00
U income_statement (quarterly, 2025-09-30) — Total Expenses: 596471000.00
U balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 3328667000.00
U balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 4160737000.00
U balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 2386432000.00
U income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: -125856000.00
U balance_sheet (quarterly, 2025-09-30) — Working Capital: 1680325000.00
U income_statement (annual, 2025-12-31) — +Operating Expense: 1850962000.00
U income_statement (quarterly, 2025-12-31) — +Operating Expense: 480360000.00
U income_statement (annual, 2025-12-31) — +Total Revenue: 1849648000.00
U income_statement (quarterly, 2025-12-31) — +Total Revenue: 503089000.00
U balance_sheet (annual, 2025-12-31) — Accounts Payable: 13981000.00
U balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 13981000.00
U balance_sheet (annual, 2025-12-31) — Accounts Receivable: 643611000.00
U balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 643611000.00
U balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -172859000.00
U balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -172859000.00
U balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 7378295000.00
U balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 7378295000.00
U balance_sheet (annual, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -10900000.00
U balance_sheet (quarterly, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -10900000.00
U cash_flow (annual, 2025-12-31) — Amortization Cash Flow: 418691000.00
U cash_flow (annual, 2025-12-31) — Amortization Of Intangibles: 418691000.00
U cash_flow (annual, 2025-12-31) — Asset Impairment Charge: 5882000.00
U cash_flow (quarterly, 2025-12-31) — Asset Impairment Charge: 971000.00
U income_statement (annual, 2025-12-31) — Basic Average Shares: 420914000.00
U income_statement (quarterly, 2025-12-31) — Basic Average Shares: 429833000.00
U income_statement (annual, 2025-12-31) — Basic EPS: -0.96
U income_statement (quarterly, 2025-12-31) — Basic EPS: -0.21
U cash_flow (annual, 2025-12-31) — Beginning Cash Position: 1527881000.00
U cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 1909088000.00
U cash_flow (annual, 2025-12-31) — Capital Expenditure: -22024000.00
U cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -5753000.00
U balance_sheet (annual, 2025-12-31) — Capital Stock: 2000.00
U balance_sheet (quarterly, 2025-12-31) — Capital Stock: 2000.00
U balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 2055840000.00
U balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 2055840000.00
U balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 2055840000.00
U balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 2055840000.00
U cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: 110091000.00
U cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: 33978000.00